Derek Robinson

Regulatory Highlights for 2006 to March 2007

This is the first in a series of reviews which will survey important developments in the area of pharmaceutical regulation, covering new initiatives and guidelines from agencies such as FDA, EMEA, ICH that particularly affect chemists developing or manufacturing active ingredients. It will also draw attention to published research and comment in the general literature which touch on these areas. It is anticipated that this section will appear twice yearly. This first article highlights developments since the beginning of 2006.